ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Supernus Pharmaceuticals, Inc. ?
1
The company is Net-Debt Free
2
Flat results in Mar 26
- NET PROFIT(9M) At USD -37.76 MM has Grown at -179.14%
- OPERATING CASH FLOW(Y) Lowest at USD 83.26 MM
- ROCE(HY) Lowest at -2.75%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 34.65%, its profits have fallen by -128%
4
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Supernus Pharmaceuticals, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Supernus Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Supernus Pharmaceuticals, Inc.
34.65%
1.92
36.23%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.68%
EBIT Growth (5y)
-174.78%
EBIT to Interest (avg)
19.82
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.65
Tax Ratio
32.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
10.50%
ROE (avg)
7.61%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.69
EV to EBIT
-59.71
EV to EBITDA
52.35
EV to Capital Employed
3.34
EV to Sales
3.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.60%
ROE (Latest)
-1.79%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET SALES(HY)
At USD 419.28 MM has Grown at 29.41%
RAW MATERIAL COST(Y)
Fallen by -0.37% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 2.63 times
DEBTORS TURNOVER RATIO(HY)
Highest at 4.74 times
NET PROFIT(Q)
At USD -1.4 MM has Grown at 70.53%
-9What is not working for the Company
NET PROFIT(9M)
At USD -37.76 MM has Grown at -179.14%
OPERATING CASH FLOW(Y)
Lowest at USD 83.26 MM
ROCE(HY)
Lowest at -2.75%
Here's what is working for Supernus Pharmaceuticals, Inc.
Net Sales
At USD 419.28 MM has Grown at 29.41%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
At USD -1.4 MM has Grown at 70.53%
over average net sales of the previous four periods of USD -4.76 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 2.63 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 4.74 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -0.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 26.14 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for Supernus Pharmaceuticals, Inc.
Operating Cash Flow
Lowest at USD 83.26 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
